Study guide

6.6 Implants, Explants, Radiation & Hazardous Materials

Certified Ambulatory Surgery Nurse CNAMB

Track your progress as you read

Finished sections get a check mark.

1 CNAMB Exam Blueprint, Eligibility & Test Strategy

Current CNAMB Exam Facts, Eligibility & Blueprint

2 Chapter 1: Preoperative Health Assessment & Diagnostic Evaluation

1.1 Patient Health History, Physical Assessment & Medication Reconciliation 1.2 Laboratory, Diagnostic & Cardiac Data Review in Ambulatory Surgery 1.3 Allergy Screening, Sensitivity Identification & Latex Precautions

3 Chapter 2: Risk Stratification, Anesthesia Screening & Pre-Op Clearance

2.1 ASA Physical Status Classification & ASC Patient Candidacy Criteria 2.2 Obstructive Sleep Apnea, Cardiovascular & Metabolic Risk Stratification

4 Chapter 3: Ambulatory Surgical Care Planning & Infection Prophylaxis

3.1 Perioperative Nursing Diagnoses & Individualized Ambulatory Care Plans 3.2 Surgical Site Infection (SSI) Prevention Bundles & Prophylactic Antibiotic Timing

5 Chapter 4: Patient Education, Vulnerable Populations & Discharge Prep

4.1 Preoperative Patient & Escort Education, Fasting Guidelines & NPO Rules 4.2 Health Literacy, Language Access & Cultural/Spiritual Care 4.3 Pediatric & Geriatric Ambulatory Care

6 Chapter 5: Surgical Asepsis, Sterile Technique & OR Environment

5.1 Principles of Surgical Asepsis, Sterile Field Integrity & Traffic Control 5.2 Surgical Hand Antisepsis, Gowning, Gloving & Draping Standards 5.3 Ambulatory OR Environmental Controls: HVAC, Temperature, Humidity & Air Exchanges

7 Chapter 6: Patient Positioning, Equipment Safety & Intraoperative Monitoring

6.1 Surgical Positioning: Alignment, Pressure Injury Prevention & Nerve Protection 6.2 Safe Use of Electrosurgery Units (ESU), Surgical Lasers & Smoke Evacuation 6.3 Intraoperative Patient Monitoring & Anesthesia Assist (MAC, General, Regional) 6.4 Surgical Counts, Specimen Management Protocols & Wound Classification 6.5 Intraoperative Medication, Solution & Fluid Safety 6.6 Implants, Explants, Radiation & Hazardous Materials

8 Chapter 7: Interdisciplinary Communication & Handoff Protocols

7.1 Structured Handoff Protocols: SBAR, IPASS & Care Transitions in the ASC 7.2 Universal Protocol, Time-Out Verification & Wrong-Site Surgery Prevention

9 Chapter 8: Clinical Documentation, Electronic Health Records & Informed Consent

8.1 Ambulatory Nursing Documentation Standards, Timelines & Legal Integrity 8.2 Informed Consent Verification, Patient Autonomy & Refusal of Care

10 Chapter 9: Phase I Postanesthesia Care & Complication Management

9.1 Phase I PACU Airway Management, Oxygenation & Hemodynamic Stabilization 9.2 Postoperative Pain Management & PONV Multimodal Protocols in the ASC 9.3 Emergent Postoperative Complications: Laryngospasm, Hemorrhage & Hypothermia

11 Chapter 10: Phase II Recovery, Discharge Criteria & Post-Discharge Safety

10.1 Aldrete Scoring, PADSS (Post-Anesthesia Discharge Scoring System) & Discharge Readiness 10.2 Patient & Escort Discharge Instructions, Home Care & Follow-Up

12 Chapter 11: Instrument Processing, Sterilization & Supply Management

11.1 Point-of-Use Treatment, Decontamination & Cleaning of Surgical Instruments 11.2 High-Level Disinfection, Steam Sterilization & Low-Temperature Methods 11.3 Sterilization Process Monitoring: Chemical/Biological Indicators & Sterile Storage

13 Chapter 12: Ambulatory Perioperative Emergencies

12.1 Malignant Hyperthermia: Presentation, Ryanodex/Dantrolene Protocol & ASC Preparedness 12.2 Local Anesthetic Systemic Toxicity (LAST): Recognition, Lipid Emulsion & Resuscitation 12.3 Surgical Suite Fires, Code Blue & Emergency Transfer/Evacuation in the ASC 12.4 Anaphylaxis, Hemorrhage, Age-Specific Arrest & Disaster Response

14 Chapter 13: Management of Personnel, Services, and Materials

13.1 ASC Staffing Models, Competency Verification & Rapid Turnover Coordination 13.2 Inventory Management, Surgeon Preference Cards & Cost-Containment Strategies 13.3 Medical Device Safety, Preventive Maintenance & Vendor Management 13.4 Product Evaluation, Recalls, PPE & Environmental Stewardship

15 Chapter 14: Legal Standards, Regulatory Framework & Professional Ethics

14.1 Nursing Scope of Practice, UAP Delegation & ANA/AORN Professional Standards 14.2 Ethics in Ambulatory Care: Patient Advocacy, Confidentiality (HIPAA) & Mandatory Reporting 14.3 Competence, Bias, Civility & Evidence-Based Practice

16 Chapter 15: Quality Improvement, Accreditation & Evidence-Based Practice

15.1 ASC Accreditation Standards: AAAHC, The Joint Commission & CMS Conditions for Coverage 15.2 Quality Improvement, Infection Surveillance (NHSN), Incident Reporting & Root Cause Analysis 15.3 Certification Value, Professional Growth & Lifelong Learning (CCI CNAMB Maintenance)

6.6 Implants, Explants, Radiation & Hazardous Materials

Key Takeaways Explain This Topic AI

Implant safety requires pre-case availability, correct-patient and correct-site verification, package-integrity and expiration checks, compatibility confirmation, and traceable lot, serial, size, and manufacturer documentation.

An explanted device is handled according to the surgeon’s order, pathology requirements, facility policy, manufacturer or legal investigation needs, and patient-release rules; chain of custody is preserved when investigation is possible.

Radiation protection follows ALARA using time, distance, and shielding, with controlled access, dosimetry, pregnancy accommodations, and correct C-arm positioning practices.

Hazardous chemicals and pharmaceuticals require accessible safety data, appropriate PPE, spill procedures, exposure reporting, and waste segregation.

Last updated: September 2026

Implants, Explants, Radiation & Hazardous Materials

Core principle: A device or hazard is safe only when the team can identify it, verify it, control exposure, and reconstruct what occurred. Traceability and chain of custody are clinical safety tools, not merely supply tasks.

Implant Readiness and Verification

Before the patient enters the operating room, confirm that the correct implant system, sizes, compatible components, instruments, backups, and manufacturer instructions are available. Loaner sets are considered contaminated on receipt and undergo the receiving facility’s complete decontamination and sterilization process. The facility establishes a delivery lead time long enough for inventory, disassembly, cleaning, inspection, packaging, sterilization, monitoring, cooling, and documentation; national standards do not create a universal 24- or 48-hour delivery mandate.

Immediately before opening an implant, match it to the order, procedure, laterality, patient anatomy, and surgeon confirmation. Inspect packaging, seal integrity, sterilization indicator, expiration date, and evidence of moisture or damage. Confirm compatibility among components; devices from different systems are not mixed unless the manufacturers expressly support the combination. If any identifier or package is questionable, quarantine it and obtain a verified replacement.

Record the implant’s name, manufacturer, model, size, lot or batch number, serial number when present, expiration date, anatomic location, and quantity. Place the implant sticker in the record only after matching it against the package; the sticker is not a substitute for visual and verbal verification. Document waste or non-implantation of an opened product. Follow applicable patient implant-information requirements and ensure the handoff includes restrictions, device-specific precautions, and follow-up needs.

Implant Sterility and Biological Monitoring

Sterilized implant loads receive the monitoring required by the device instructions, sterilizer instructions, facility policy, and applicable processing standards. Implant release is ordinarily held until the biological indicator result is available. Emergency release should be exceptional, authorized, justified, and fully documented with traceability and follow-up. Convenience, inventory shortage, or poor scheduling is not an emergency. Immediate-use steam sterilization is not a routine solution for insufficient implant inventory.

Explants and Foreign Bodies

An explanted device may be a pathology specimen, a potential source for culture, evidence in a device investigation, a manufacturer return, or property requested by the patient. Before cleaning, alteration, or release, clarify the surgeon’s order and facility pathway. Preserve attached tissue when pathology examination is required. If device failure may have caused serious injury, retain the device and accessories in their post-event state, quarantine them, document identifiers, and coordinate risk management and mandatory reporting. Maintain a signed chain of custody whenever possession changes.

A patient request for an explant does not override biohazard, pathology, legal-hold, or manufacturer-investigation requirements. Release occurs only under approved policy after required examinations, decontamination decisions, documentation, and acknowledgment of hazards. Never place an unidentified explant in a personal belongings bag.

Ionizing Radiation: ALARA

ALARA means keeping exposure as low as reasonably achievable . Minimize beam-on time, maximize distance from the source, and use shielding. Wear correctly fitted lead apron and thyroid protection when indicated, position mobile shields, and use assigned dosimeters at the location specified by the radiation-safety program. Staff do not share badges. Restrict room access, announce imaging, and keep hands out of the primary beam. For a C-arm, the x-ray tube side generally produces more scatter than the image-receptor side; maximize distance and stand on the lower-scatter side when clinical duties permit.

Pregnancy disclosure is voluntary and handled confidentially through the radiation-safety program. A declared pregnancy triggers occupational dose review and reasonable work controls; it is not an automatic reason to remove a competent employee from all imaging cases. Document equipment checks and follow policies for credentialing operators and wearing eye or extremity protection when exposure warrants it.

Hazard Communication and Exposure Response

Hazardous materials in the ASC may include formaldehyde, glutaraldehyde or other high-level disinfectants, cleaning concentrates, waste anesthetic gases, cytotoxic agents, compressed gases, and battery or laser-plume contaminants. Labels remain intact, safety data sheets are accessible, and staff know ventilation, PPE, storage incompatibilities, and spill procedures. Secondary containers are labeled; chemicals are never stored in beverage containers.

For a splash or inhalation exposure, stop work, remove the person from exposure, use the eyewash or safety shower for the product-specified duration, remove contaminated clothing, and obtain medical evaluation. Report and document the exposure promptly. Use the designated spill kit only when trained and when the spill is within the facility’s response capability; otherwise isolate the area and activate external hazardous-material support. Segregate sharps, red-bag waste, pharmaceuticals, hazardous chemicals, and regulated device waste according to law and facility contracts.

Loading diagram... Implant and Explant Traceability Pathway